DK3713928T3 - Hidtil ukendte bradykinin-b2-receptorantagonister - Google Patents
Hidtil ukendte bradykinin-b2-receptorantagonister Download PDFInfo
- Publication number
- DK3713928T3 DK3713928T3 DK18818992.2T DK18818992T DK3713928T3 DK 3713928 T3 DK3713928 T3 DK 3713928T3 DK 18818992 T DK18818992 T DK 18818992T DK 3713928 T3 DK3713928 T3 DK 3713928T3
- Authority
- DK
- Denmark
- Prior art keywords
- bradykinin
- receptor antagonists
- still unknown
- unknown
- still
- Prior art date
Links
- 229940123765 Bradykinin B2 receptor antagonist Drugs 0.000 title 1
- 239000003359 bradykinin B2 receptor antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17203675 | 2017-11-24 | ||
| PCT/EP2018/082338 WO2019101906A1 (en) | 2017-11-24 | 2018-11-23 | Novel bradykinin b2 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3713928T3 true DK3713928T3 (da) | 2022-04-04 |
Family
ID=60473364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18818992.2T DK3713928T3 (da) | 2017-11-24 | 2018-11-23 | Hidtil ukendte bradykinin-b2-receptorantagonister |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US10836748B2 (da) |
| EP (2) | EP3998259A1 (da) |
| JP (2) | JP7164619B2 (da) |
| KR (1) | KR102413321B1 (da) |
| CN (1) | CN111433196B (da) |
| AR (1) | AR113839A1 (da) |
| AU (1) | AU2018371186B2 (da) |
| BR (1) | BR112020010298A2 (da) |
| CA (1) | CA3082948A1 (da) |
| DK (1) | DK3713928T3 (da) |
| EA (1) | EA202091256A1 (da) |
| ES (1) | ES2908409T3 (da) |
| HR (1) | HRP20220429T1 (da) |
| HU (1) | HUE058217T2 (da) |
| IL (1) | IL274883B2 (da) |
| LT (1) | LT3713928T (da) |
| MA (1) | MA50804B1 (da) |
| MX (1) | MX2020005287A (da) |
| NZ (1) | NZ764304A (da) |
| PH (1) | PH12020550683A1 (da) |
| PL (1) | PL3713928T3 (da) |
| PT (1) | PT3713928T (da) |
| RS (1) | RS63087B1 (da) |
| SG (1) | SG11202004653TA (da) |
| SI (1) | SI3713928T1 (da) |
| TW (1) | TWI768156B (da) |
| UY (1) | UY37981A (da) |
| WO (1) | WO2019101906A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2908409T3 (es) | 2017-11-24 | 2022-04-29 | Pharvaris Netherlands B V | Antagonistas novedosos del receptor B2 de bradiquinina |
| AR118982A1 (es) * | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| AR118983A1 (es) | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| EP4243824A1 (en) | 2020-11-12 | 2023-09-20 | Pharvaris GmbH | Prophylaxis and treatment of angioedema |
| WO2023012324A1 (en) | 2021-08-05 | 2023-02-09 | Pharvaris Gmbh | Solid form of a bradykinin b2-receptor antagonist |
| CA3227476A1 (en) | 2021-08-05 | 2023-02-09 | Christoph Gibson | Lipid-based composition for oral administration of bradykinin b2-receptor antagonists |
| TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物 |
| WO2023180577A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Therapeutic uses of bradykinin b2-receptor antagonists |
| WO2023180575A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Solid composition comprising solubilised bradykinin b2-receptor antagonists |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU680870B2 (en) | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
| CA2203659A1 (en) | 1994-10-27 | 1996-05-09 | Teruo Oku | Pyridopyrimidones, quinolines and fused n-heterocycles as bradykinin antagonists |
| FR2737892B1 (fr) | 1995-08-17 | 1997-10-24 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique |
| GB9602029D0 (en) | 1996-02-01 | 1996-04-03 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
| DE19609827A1 (de) | 1996-03-13 | 1997-09-18 | Hoechst Ag | Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten |
| DE19610784A1 (de) | 1996-03-19 | 1997-09-25 | Hoechst Ag | Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE19612067A1 (de) | 1996-03-27 | 1997-10-02 | Hoechst Ag | Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen |
| AUPN952696A0 (en) | 1996-04-29 | 1996-05-23 | Fujisawa Pharmaceutical Co., Ltd. | New heterocyclic compounds |
| DE19712960A1 (de) | 1997-03-27 | 1998-10-01 | Hoechst Ag | Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten |
| AU4335299A (en) | 1998-06-08 | 1999-12-30 | Advanced Medicine, Inc. | Bradykinin antagonists |
| IL142460A0 (en) | 1998-10-21 | 2002-03-10 | Fujisawa Pharmaceutical Co | A vitreous form of 8-[3-[n-[(e)-3-(6-acetamidopyridin-3-yl) acryloyl-glycyl] -n-methylamino] -2,6-dichlorobenzyloxy]-2-methylquinoline |
| FR2790260B1 (fr) | 1999-02-26 | 2001-05-04 | Fournier Ind & Sante | Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique |
| GB9913079D0 (en) | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
| US6509366B2 (en) | 2000-01-18 | 2003-01-21 | Neurogen Corporation | Substituted imidazoles as selective modulators of Bradykinin B2 receptors |
| CA2364178C (en) | 2000-12-05 | 2006-01-10 | Yasuhiro Katsu | N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| EP1495017A2 (en) | 2002-04-10 | 2005-01-12 | Ortho-McNeil Pharmaceutical, Inc. | Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| ITMI20021247A1 (it) | 2002-06-07 | 2003-12-09 | Menarini Ricerche Spa | Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche |
| ITMI20041963A1 (it) | 2004-10-15 | 2005-01-15 | Luso Farmaco Inst | "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche" |
| EP1741444A1 (en) | 2005-07-05 | 2007-01-10 | Jerini AG | Kinin antagonists for treating bladder dysfunction |
| TWI407960B (zh) * | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽ｂ２受體調節劑 |
| AR073304A1 (es) | 2008-09-22 | 2010-10-28 | Jerini Ag | Moduladores del receptor de bradiquinina b2 de molecula pequena |
| KR20150127718A (ko) | 2013-03-14 | 2015-11-17 | 샤이어 휴먼 지네틱 테라피즈 인크. | Ｂ2-브라디키닌 수용체 매개 혈관부종의 치료 방법 |
| ES2908409T3 (es) | 2017-11-24 | 2022-04-29 | Pharvaris Netherlands B V | Antagonistas novedosos del receptor B2 de bradiquinina |
-
2018
- 2018-11-23 ES ES18818992T patent/ES2908409T3/es active Active
- 2018-11-23 EA EA202091256A patent/EA202091256A1/ru unknown
- 2018-11-23 PT PT188189922T patent/PT3713928T/pt unknown
- 2018-11-23 JP JP2020545875A patent/JP7164619B2/ja active Active
- 2018-11-23 SG SG11202004653TA patent/SG11202004653TA/en unknown
- 2018-11-23 MA MA50804A patent/MA50804B1/fr unknown
- 2018-11-23 DK DK18818992.2T patent/DK3713928T3/da active
- 2018-11-23 EP EP21213719.4A patent/EP3998259A1/en active Pending
- 2018-11-23 HR HRP20220429TT patent/HRP20220429T1/hr unknown
- 2018-11-23 EP EP18818992.2A patent/EP3713928B1/en active Active
- 2018-11-23 LT LTEPPCT/EP2018/082338T patent/LT3713928T/lt unknown
- 2018-11-23 HU HUE18818992A patent/HUE058217T2/hu unknown
- 2018-11-23 AU AU2018371186A patent/AU2018371186B2/en active Active
- 2018-11-23 BR BR112020010298-9A patent/BR112020010298A2/pt unknown
- 2018-11-23 AR ARP180103444A patent/AR113839A1/es unknown
- 2018-11-23 TW TW107141872A patent/TWI768156B/zh active
- 2018-11-23 SI SI201830628T patent/SI3713928T1/sl unknown
- 2018-11-23 MX MX2020005287A patent/MX2020005287A/es unknown
- 2018-11-23 PL PL18818992T patent/PL3713928T3/pl unknown
- 2018-11-23 CN CN201880076162.XA patent/CN111433196B/zh active Active
- 2018-11-23 KR KR1020207017972A patent/KR102413321B1/ko active IP Right Grant
- 2018-11-23 WO PCT/EP2018/082338 patent/WO2019101906A1/en unknown
- 2018-11-23 UY UY0001037981A patent/UY37981A/es unknown
- 2018-11-23 IL IL274883A patent/IL274883B2/en unknown
- 2018-11-23 CA CA3082948A patent/CA3082948A1/en active Pending
- 2018-11-23 RS RS20220335A patent/RS63087B1/sr unknown
- 2018-11-23 NZ NZ764304A patent/NZ764304A/en unknown
-
2020
- 2020-04-28 US US16/861,131 patent/US10836748B2/en active Active
- 2020-05-21 PH PH12020550683A patent/PH12020550683A1/en unknown
- 2020-09-25 US US17/033,347 patent/US11261173B2/en active Active
-
2022
- 2022-01-18 US US17/578,161 patent/US11820756B2/en active Active
- 2022-10-20 JP JP2022168473A patent/JP2023002701A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3642224T3 (da) | T-cellereceptorer | |
| DK3713928T3 (da) | Hidtil ukendte bradykinin-b2-receptorantagonister | |
| DK3666771T3 (da) | Lpa-antagonister | |
| DK3440105T3 (da) | T-cellereceptorer | |
| DK3440106T3 (da) | T-cellereceptorer | |
| DK3368060T3 (da) | Glugacon-receptor-agonister | |
| MA44629A (fr) | Antagonistes de c5ar solubles | |
| DK3448882T3 (da) | Anti-kk-lc-1-t-cellereceptorer | |
| DK3274366T3 (da) | Kimær antigenreceptor | |
| DK3494133T3 (da) | Anti-kras-g12d-t-cellereceptorer | |
| DK3515887T3 (da) | TRPV4-antagonister | |
| DK3762380T3 (da) | Phenylpyrrolidinon-formylpeptid-2-receptoragonister | |
| DK3143037T3 (da) | Alpha4beta7-integrin-thioether-peptidantagonister | |
| DK3606961T3 (da) | Garp-tgf-beta-antistoffer | |
| DK3820873T3 (da) | Selektive østrogenreceptornedbrydere | |
| DK3672951T3 (da) | Quinoxalinderivater som adenosinreceptorantagonister | |
| DK3212637T3 (da) | Dopamin-d3-receptorantagonistforbindelser | |
| IL258892B (en) | Calcitonin gene-related peptide receptor antagonists | |
| DK3334721T3 (da) | Cgrp-receptorantagonister | |
| DK3490986T3 (da) | Piperidin-cxcr7-receptormodulatorer | |
| DK3820874T3 (da) | Selektive estrogenreceptornedbrydere | |
| DK3661941T3 (da) | Thiazolopyridinderivater som adenosinreceptor-antagonister | |
| GB201519194D0 (en) | CGRP receptor antagonists | |
| DK3412840T3 (da) | Toilet | |
| IT201700072559A1 (it) | Interfaccia aptica |